A review evaluated the distribution and predictive capabilities of three genomic assays for breast cancer across different ...

Cambridge researchers developed PRRDetect, an algorithm identifying tumors with DNA repair faults, enhancing personalized ...

Even among patients with prostate cancer liver metastasis who have a poor prognosis, elevated ctDNA fraction and tumor suppressor gene loss differentiate survival.

Genomic testing, while sometimes a difficult subject to navigate with patients, is an essential part of oncology in which nurses and advanced practice providers (APPs) should be well-versed, according ...

--(BUSINESS WIRE)--Arima Genomics, Inc. (Arima), a company leveraging ... Weill Cornell School of Medicine, Scripps Cancer Center, Moores Cancer Center at the University of California, San Diego ...

Fasting has shown its potential to reduce colorectal cancer risk by triggering cellular changes that may slow tumor growth, ...

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following ...

Aurora-based Children’s Hospital Colorado has opened an in-house genomics testing lab through its Precision Medicine Institute.  The lab enables genomic testing results to be more quickly integrated ...

In his talk, Dr. Perou will share his journey from research to entrepreneurship, highlighting the challenges and lessons learned in transforming his cancer genomics research into a successful startup ...

Results of a study show convergent genetic adaptation under hypoxia (lack of oxygen) between populations living at ...

A new study shows that Arima Genomics’ technology detects actionable cancer drivers in solid tumors missed by FISH, RNA, and DNA sequencing tests.